These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease. Coller BA; Clements DE; Bett AJ; Sagar SL; Ter Meulen JH Vaccine; 2011 Sep; 29(42):7267-75. PubMed ID: 21777637 [TBL] [Abstract][Full Text] [Related]
6. Dengue vaccine development by the year 2020: challenges and prospects. Wilder-Smith A Curr Opin Virol; 2020 Aug; 43():71-78. PubMed ID: 33086187 [TBL] [Abstract][Full Text] [Related]
7. Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence. Sun J; Li M; Wang Y; Hao P; Jin X Vaccine; 2017 Nov; 35(46):6308-6320. PubMed ID: 28987441 [TBL] [Abstract][Full Text] [Related]
8. Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus. Lazo L; Izquierdo A; Suzarte E; Gil L; Valdés I; Marcos E; Álvarez M; Romero Y; Guzmán MG; Guillén G; Hermida Cruz L Microbiol Immunol; 2014 Apr; 58(4):219-26. PubMed ID: 24689365 [TBL] [Abstract][Full Text] [Related]
9. A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies. Faheem M; Raheel U; Riaz MN; Kanwal N; Javed F; us Sahar Sadaf Zaidi N; Qadri I Mol Biol Rep; 2011 Aug; 38(6):3731-40. PubMed ID: 21107723 [TBL] [Abstract][Full Text] [Related]
10. Current progress in dengue vaccines. Wan SW; Lin CF; Wang S; Chen YH; Yeh TM; Liu HS; Anderson R; Lin YS J Biomed Sci; 2013 Jun; 20(1):37. PubMed ID: 23758699 [TBL] [Abstract][Full Text] [Related]
11. A novel immunization approach for dengue infection based on conserved T cell epitopes formulated in calcium phosphate nanoparticles. Huang X; Karabudak A; Comber JD; Philip M; Morcol T; Philip R Hum Vaccin Immunother; 2017 Nov; 13(11):2612-2625. PubMed ID: 28933657 [TBL] [Abstract][Full Text] [Related]
12. [Research progress in the structure and function of dengue virus non-structural 1 protein]. Chen Y; Ren RW; Liu JW Bing Du Xue Bao; 2014 Nov; 30(6):683-8. PubMed ID: 25868284 [TBL] [Abstract][Full Text] [Related]
13. Review of dengue virus and the development of a vaccine. Murrell S; Wu SC; Butler M Biotechnol Adv; 2011; 29(2):239-47. PubMed ID: 21146601 [TBL] [Abstract][Full Text] [Related]
14. A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates. Chen HW; Liu SJ; Li YS; Liu HH; Tsai JP; Chiang CY; Chen MY; Hwang CS; Huang CC; Hu HM; Chung HH; Wu SH; Chong P; Leng CH; Pan CH Arch Virol; 2013 Jul; 158(7):1523-31. PubMed ID: 23456422 [TBL] [Abstract][Full Text] [Related]
15. Dengue vaccine candidates in development. Durbin AP; Whitehead SS Curr Top Microbiol Immunol; 2010; 338():129-43. PubMed ID: 19802583 [TBL] [Abstract][Full Text] [Related]